117 related articles for article (PubMed ID: 38282581)
1. Arecoline promotes Akt-c-Myc-driven aerobic glycolysis in esophageal epithelial cells.
Han S; Chen Y; Huang Y; Jin L; Ma Y
Environ Toxicol; 2024 May; 39(5):2794-2802. PubMed ID: 38282581
[TBL] [Abstract][Full Text] [Related]
2. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
[TBL] [Abstract][Full Text] [Related]
3. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.
Hua Q; Jin M; Mi B; Xu F; Li T; Zhao L; Liu J; Huang G
J Hematol Oncol; 2019 Sep; 12(1):91. PubMed ID: 31488218
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic effect of compound K in hepatocellular carcinoma cells via inhibition of glycolysis and Akt/mTOR/c-Myc signaling.
Shin N; Lee HJ; Sim DY; Im E; Park JE; Park WY; Cho AR; Shim BS; Kim SH
Phytother Res; 2021 Jul; 35(7):3812-3820. PubMed ID: 33856720
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
6. RNF130 protects against pulmonary fibrosis through suppressing aerobic glycolysis by mediating c-myc ubiquitination.
Zhang J; Chen W; Du J; Chu L; Zhou Z; Zhong W; Liu D; Huang H; Huang Y; Qiao Y; Meng X; Zou F; Cai S; Dong H
Int Immunopharmacol; 2023 Apr; 117():109985. PubMed ID: 36893517
[TBL] [Abstract][Full Text] [Related]
7. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
8. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis.
Fang Y; Shen ZY; Zhan YZ; Feng XC; Chen KL; Li YS; Deng HJ; Pan SM; Wu DH; Ding Y
Nat Commun; 2019 Sep; 10(1):3981. PubMed ID: 31484922
[TBL] [Abstract][Full Text] [Related]
9. Arsenic exposure elevated ROS promotes energy metabolic reprogramming with enhanced AKT-dependent HK2 expression.
Lou Q; Zhang M; Zhang K; Liu X; Zhang Z; Zhang X; Yang Y; Gao Y
Sci Total Environ; 2022 Aug; 836():155691. PubMed ID: 35525345
[TBL] [Abstract][Full Text] [Related]
10. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
Parajuli P; Tiwari RV; Sylvester PW
Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
[TBL] [Abstract][Full Text] [Related]
12. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
[TBL] [Abstract][Full Text] [Related]
13. Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition.
Fan Y; Dickman KG; Zong WX
J Biol Chem; 2010 Mar; 285(10):7324-33. PubMed ID: 20018866
[TBL] [Abstract][Full Text] [Related]
14. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B
Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748
[TBL] [Abstract][Full Text] [Related]
15. Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M.
Chuerduangphui J; Ekalaksananan T; Chaiyarit P; Patarapadungkit N; Chotiyano A; Kongyingyoes B; Promthet S; Pientong C
PLoS One; 2018; 13(1):e0192009. PubMed ID: 29385191
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
[TBL] [Abstract][Full Text] [Related]
17. Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway.
Sun Y; Chen Y; Xu M; Liu C; Shang H; Wang C
Biomed Res Int; 2020; 2020():9243681. PubMed ID: 32685545
[TBL] [Abstract][Full Text] [Related]
18. The deubiquitinating enzyme USP17 regulates c-Myc levels and controls cell proliferation and glycolysis.
Nagasaka M; Inoue Y; Yoshida M; Miyajima C; Morishita D; Tokugawa M; Nakamoto H; Sugano M; Ohoka N; Hayashi H
FEBS Lett; 2022 Feb; 596(4):465-478. PubMed ID: 35076962
[TBL] [Abstract][Full Text] [Related]
19. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
[TBL] [Abstract][Full Text] [Related]
20. FoxA2 inhibits the proliferation of hepatic progenitor cells by reducing PI3K/Akt/HK2-mediated glycolysis.
Wang P; Cong M; Liu T; Li Y; Liu L; Sun S; Sun L; Zhu Z; Ma H; You H; Zhang H; Jia J
J Cell Physiol; 2020 Dec; 235(12):9524-9537. PubMed ID: 32495363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]